avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxb5
|
ENSMUSG00000038700.3 | homeobox B5 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hoxb5 | mm10_v2_chr11_+_96302595_96302595 | 0.55 | 4.8e-04 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 14.6 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
2.8 | 28.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.4 | 7.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.2 | 4.8 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
1.1 | 3.4 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
1.0 | 3.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.8 | 3.0 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
0.7 | 2.8 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.7 | 7.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.6 | 2.5 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.5 | 2.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.5 | 2.6 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.5 | 1.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.4 | 2.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.4 | 1.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 1.2 | GO:0002352 | B cell negative selection(GO:0002352) B cell homeostatic proliferation(GO:0002358) regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.4 | 1.5 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 8.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 1.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.3 | 4.8 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 1.4 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.2 | 5.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 1.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.7 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.2 | 0.8 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.4 | GO:2000520 | lymphocyte migration into lymphoid organs(GO:0097021) positive regulation of thymocyte migration(GO:2000412) regulation of immunological synapse formation(GO:2000520) regulation of dendritic cell dendrite assembly(GO:2000547) |
0.1 | 0.7 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 1.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 1.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 1.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 2.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 1.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 1.0 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 1.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 3.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 1.0 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.1 | 0.8 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 2.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.3 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 4.1 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.0 | 1.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 2.7 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.1 | GO:0002587 | negative regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002587) |
0.0 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 5.0 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 4.7 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 1.7 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 4.2 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 1.9 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.7 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 1.3 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.3 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.5 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.6 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 2.1 | GO:1903169 | regulation of calcium ion transmembrane transport(GO:1903169) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 28.5 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
0.6 | 2.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.4 | 5.9 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 7.6 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 2.2 | GO:0044754 | autolysosome(GO:0044754) |
0.2 | 2.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 7.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 1.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 9.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 10.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.3 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.1 | 3.1 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 1.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 2.8 | GO:0016605 | PML body(GO:0016605) |
0.0 | 1.7 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 1.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 2.0 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 1.8 | GO:0005930 | axoneme(GO:0005930) |
0.0 | 1.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 2.7 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 1.9 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.5 | GO:0031902 | late endosome membrane(GO:0031902) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 14.6 | GO:0043120 | interleukin-8 binding(GO:0019959) tumor necrosis factor binding(GO:0043120) |
1.9 | 9.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.9 | 2.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.8 | 4.8 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.6 | 2.5 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.4 | 1.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 4.8 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.3 | 3.4 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.3 | 1.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 2.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.3 | 1.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 4.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 9.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 0.7 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 1.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 1.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 1.3 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 1.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 4.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 4.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.5 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.1 | 0.3 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.1 | 3.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 1.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 3.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 2.8 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 1.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 1.7 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 4.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 2.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.6 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 4.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 14.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 8.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 1.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 3.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 2.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 2.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 2.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 1.9 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 1.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 14.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 4.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 9.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 3.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 4.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 1.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 4.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 2.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 2.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 3.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 1.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 1.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 1.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 2.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 3.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 1.4 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |